identifi
oleuropein
ole
hydroxytyrosol
ht
uniqu
class
inhibitor
oliv
leaf
extract
effect
viral
fusion
integr
use
molecular
dock
simul
studi
interact
ole
ht
viral
target
find
ole
ht
bind
conserv
hydrophob
pocket
surfac
fusion
domain
hydrogen
bond
hydrophob
interact
ntermin
heptad
repeat
peptid
interf
format
fusionact
core
test
confirm
model
predic
examin
effect
ole
ht
fusion
complex
format
use
nativ
polyacrylamid
gel
electrophoresi
circular
dichroism
spectroscopi
ole
ht
exhibit
dose
depend
inhibit
fusion
core
format
ec
nm
detect
toxic
find
effect
integras
report
separ
present
drug
licens
fda
treatment
infect
unit
state
agent
classifi
accord
mechan
action
revers
transcriptas
inhibitor
rti
nucleosid
nrti
nonnucleosid
nnrti
proteas
inhibitor
pi
fusion
inhibitor
multiclass
combin
product
mccp
combin
rti
pi
commonli
known
highli
activ
antiretrovir
therapi
haart
significantli
reduc
morbid
mortal
transform
hivaid
manag
chronic
ill
although
haart
favor
influenc
diseas
progress
cure
hiv
infect
antivir
therapi
must
maintain
longterm
seriou
chronic
toxic
therapi
fatigu
drug
resist
becom
major
issu
new
therapeut
approach
includ
fusion
inhibitor
fuzeon
enfuvirtid
nonpeptid
pi
tipranavir
new
pi
darunavir
recent
approv
mccp
atripla
howev
exist
experi
highlight
need
use
multipl
effect
agent
combin
maxim
durabl
effect
thu
search
novel
antihiv
agent
continu
great
signific
especi
capabl
affect
multipl
stage
viral
life
cycl
previous
report
oliv
leaf
extract
potent
investig
antihiv
properti
discov
oleuropein
ole
main
metabolit
hydroxytyrosol
ht
key
antihiv
compon
activ
multipl
stage
life
cycl
inhibit
celltocel
transmiss
viral
core
antigen
product
molecular
dock
simul
indic
ole
ht
interact
conserv
hydrophob
pocket
surfac
central
trimer
coiledcoil
fusion
complex
six
helic
bundl
catalyt
core
domain
ccd
integras
activ
site
articl
report
find
identif
character
ole
ht
well
test
confirm
model
predict
antihiv
fusion
activ
oleuropein
ole
purifi
oliv
leaf
extract
character
standard
liquid
chromatographycoupl
mass
spectrometri
lcm
hydroxytyrosol
ht
prepar
stepwis
hydrolysi
ole
sigma
mm
sodium
acet
ph
use
substrat
hr
treatment
remov
glucos
moieti
ole
yield
oleuropein
aglycon
oleag
oleag
subsequ
hydrolyz
esteras
sigma
mm
sodium
phosphat
buffer
ph
substrat
hr
yield
hydroxytyrosol
elenol
acid
mixtur
separ
hplc
standard
lcm
ht
also
prepar
chemic
synthesi
ester
dhpa
uninfect
cell
line
iiib
chronic
infect
iiib
viru
obtain
aid
research
refer
reagent
program
niaid
nih
cell
obtain
richman
viru
stock
r
gallo
cell
line
cultur
rpmi
medium
contain
penicillin
streptomycin
mm
lglutamin
heatinactiv
fetal
calf
serum
viral
stock
prepar
standard
describ
effect
ole
ht
acut
hiv
infect
viral
replic
measur
assay
syncyti
format
cellcel
transmiss
core
protein
express
describ
cytotox
evalu
mtt
assay
molecular
model
perform
molecular
dock
molecular
dynam
md
simul
free
energi
calcul
dock
perform
autodock
version
relax
dock
structur
obtain
implement
discoveri
insight
ii
accelri
inc
san
diego
ca
usa
use
step
steepest
descent
follow
conjug
gradient
root
mean
squar
energi
gradient
reach
valu
fusion
peptid
synthes
solid
phase
fmoc
method
genem
ca
purifi
hplc
sequenc
peptid
acsgivqqqnnllraieaqqhllqltvwgikqlqarilnh
acwmewdreinnytslihslieesqnqqekneqellnh
respect
correspond
viral
peptid
prepar
obtain
nih
aid
research
refer
reagent
program
niaid
nih
use
standard
purif
bioassay
fusion
complex
format
carri
incub
equimolar
amount
fusion
peptid
pb
phosphat
buffer
salin
contain
sodium
phosphat
ph
mm
nacl
peptid
first
incub
either
alon
variou
concentr
ole
ht
min
next
equimolar
amount
ad
sampl
incub
min
npage
carri
previous
report
modif
involv
fusion
peptid
concentr
order
reaction
time
incub
fusion
complex
format
trisglycin
gel
invitrogen
carlsbad
ca
electrophores
v
stain
coomassi
blue
analyz
densitometri
cd
spectra
record
aviv
cd
spectromet
use
mm
sampl
cell
fix
temperatur
spectrum
smooth
averag
scan
bandwidth
measur
nm
cd
intens
express
mean
residu
ellipt
degre
cm
dmol
prior
calcul
final
ellipt
spectra
correct
subtract
refer
spectra
pb
without
peptid
figur
repres
lcm
analysi
ole
ht
ole
fraction
singl
peak
hplc
min
mz
ht
singl
peak
hplc
min
mz
figur
show
major
step
ole
metabol
also
basic
reaction
ht
prepar
ole
first
glucos
moieti
remov
yield
oleuropein
aglycon
oleag
next
oleag
hydrolyz
esteras
yield
ht
elenol
acid
ea
figur
show
chemic
synthesi
ht
use
acid
dhpaa
start
materi
two
major
step
involv
acetyl
acetyl
chlorid
accl
reduct
lialh
yield
ht
chemic
synthes
ht
purifi
character
lcm
demonstr
ident
biolog
chemic
physic
properti
natur
ht
prepar
ole
oliv
leaf
extract
ole
ht
exhibit
dose
depend
inhibit
infect
replic
measur
syncyti
format
product
tabl
averag
ec
ole
nm
syncyti
format
nm
product
correspond
ec
nm
nm
ht
cytotox
detect
either
mtt
assay
trypan
blue
dye
exclus
concentr
rang
nm
ec
inhibit
fusion
complex
format
also
present
tabl
inhibit
syncyti
format
ole
ht
reflect
effect
earli
event
viral
infectionentri
includ
receptor
coreceptor
bind
well
viral
fusion
probe
antihiv
mechan
ole
ht
carri
molecular
dock
md
calcul
small
molecul
viral
target
found
ole
ht
bind
conserv
hydrophob
pocket
surfac
central
trimer
coiledcoil
fusion
domain
envelop
glycoprotein
env
mediat
viral
entri
fuse
viru
target
cell
env
trimer
virion
surfac
monom
contain
surfac
subunit
viru
bind
receptor
coreceptor
noncoval
associ
transmembran
subunit
mediat
fusion
viru
target
cell
figur
show
structur
like
type
transmembran
protein
consist
extracellular
ectodomain
transmembran
cytoplasm
domain
ectodomain
contain
four
function
region
fusion
peptid
ntermin
heptad
repeat
nhr
ctermin
heptad
repeat
chr
tryptophanrich
region
bind
cellular
receptor
coreceptor
trigger
conform
chang
induc
fusion
increas
exposur
two
heptad
repeat
motif
nhr
chr
insert
fusion
peptid
target
membran
subsequ
nhr
chr
fold
antiparallel
manner
creat
sixhelix
bundl
compos
trimer
nhr
coiledcoil
core
surround
three
chr
helic
pack
groov
coiledcoil
seen
figur
format
promot
fusion
viral
cellular
membran
essenti
viral
entri
infect
ole
ht
interact
nhr
coiledcoil
trimer
helic
interfer
format
chr
shown
figur
use
crystal
structur
fusion
complex
pdb
code
refer
model
work
provid
ligand
bind
site
one
helic
remov
figur
figur
show
chemic
structur
ole
free
rotat
bond
select
model
interact
molecular
simul
suggest
conserv
hydrophob
caviti
trimer
coiledcoil
like
bind
site
ole
ht
caviti
mainli
occupi
neighbor
predict
bind
structur
ole
ht
shown
figur
respect
ole
ht
form
stabl
hydrogen
bond
peptid
figur
ribbon
represent
predict
bind
site
ole
ht
consist
three
pink
residu
two
peptid
green
residu
use
dock
calcul
one
groov
expos
bind
small
molecul
ole
ht
occupi
bind
site
similarli
diphenol
ring
form
stabl
hydrogen
bond
block
close
contact
hydrophob
groov
nhr
indol
ring
thu
interf
format
addit
hydrogen
bind
hydrophob
interact
g
l
also
play
import
role
interact
test
predict
molecular
model
examin
effect
ole
ht
format
fusion
complex
electrophoret
mobil
shift
use
nativepag
figur
electrod
connect
cathod
neg
termin
top
anod
posit
termin
bottom
peptid
move
electr
field
accord
charg
size
peptid
carri
net
neg
charg
move
toward
posit
termin
bottom
wherea
peptid
carri
net
posit
charg
move
toward
neg
termin
remain
top
well
incub
result
format
fusion
complex
larger
move
slower
free
thu
migrat
middl
gel
preincub
ole
ht
result
inhibit
format
dosedepend
disappear
band
detect
concomit
appear
free
band
total
inhibit
achiev
nm
ole
ht
ec
around
nm
result
confirm
predict
molecular
model
also
use
cd
analysi
confirm
molecular
model
predict
figur
singl
strand
random
coil
assum
order
structur
solut
display
characterist
random
coil
cd
spectra
howev
format
fusion
complex
result
distinct
cd
spectrum
includ
saddleshap
neg
peak
nm
far
uv
region
signific
increas
molar
ellipt
nm
preincub
ole
ht
interrupt
format
result
dose
depend
shift
cd
spectra
helic
random
coil
ec
nm
ole
nm
ht
ole
ht
small
molecul
molecular
weight
respect
inhibit
fusionpromot
refold
excel
exampl
small
molecul
block
format
proteinprotein
complex
narrow
target
bind
hydrophob
pocket
inner
core
pocket
highli
conserv
among
differ
hiv
clade
consist
found
ole
ht
activ
panel
primari
isol
includ
tropic
strain
differ
clade
result
suggest
ole
ht
may
use
virus
type
transmembran
envelop
glycoprotein
includ
sever
acut
respiratori
syndrom
associ
coronaviru
respiratori
syncyti
viru
ebola
viru
measl
viru
avian
flu
fuzeon
enfuvirtid
fda
approv
hiv
fusion
inhibitor
peptid
deriv
chr
region
partial
overlap
sequenc
fuzeon
commerci
produc
chemic
synthesi
larg
sizeit
consist
amino
acid
molecular
weight
manufactur
process
complex
involv
chemic
step
contrast
typic
process
chemic
synthesi
ht
involv
two
step
acetyl
reduct
figur
addit
ole
ht
also
easili
prepar
natur
oliv
leaf
extract
two
step
deglycosyl
oxid
figur
fact
ole
ht
act
outsid
insid
cellular
environ
viral
entri
integr
offer
uniqu
benefit
small
molecul
viral
resist
